JAZZ Venture Partners — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Magnus Medical develops SAINT, an FDA-cleared, accelerated form of TMS (transcranial magnetic stimulation) therapy that uses precision neuromodulation to treat Major Depressive Disorder, including treatment-resistant depression, over a 5-day course.
BiotechDigital HealthMedical DevicesMental HealthBurlingame, US
Nolan Williams(Director)Christian Gormsen(Executive Officer, Director)Vikram Lamba(Executive Officer)
BoardXingjuan Chao(Director)Andrew Firlik(Director)inHeath Lukatch(Director)
Co-investorsDolby Family VenturesRed Tree Venture
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.